Clinical Trials Browser

Leukemia, Myeloid, Acute × camrelizumab × Clear all

NCT05772273 2025-11-21

PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCT

Phase NA Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04353479 2020-04-20

Combined PD1 Inhibitor and Decitabine in Elderly Patients With Relapse and Refractory Acute Myeloid Leukemia

Phase 2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute